Prognosis and Treatment of Bile Duct Carcinoma

Chung, Christopher; Bautista, Norman
October 1998
American Surgeon;Oct1998, Vol. 64 Issue 10, p921
Academic Journal
Identifies prognostic factors to better delineate therapeutic options for bile duct carcinomas. Carcinoma of upper third bile duct; Carcinoma of middle third bile duct; Carcinoma of lower third bile duct; Diffuse bile duct carcinoma; Tumor histology; Prognostic classification.


Related Articles

  • Caveolin-I overexpression is a favourable prognostic factor for patients with extrahepatic bile duct carcinoma. Murakami, S.; Miyamoto, M.; Hida, Y.; Cho, Y.; Fukunaga, A.; Oshikiri, T.; Kato, K.; Kurokawa, T.; Suzuoki, M.; Nakakubo, Y.; Hiraoka, K.; Itoh, T.; Shinohara, T.; Morikawa, T.; Okushiba, S.; Kondo, S.; Katoh, H. // British Journal of Cancer;4/22/2003, Vol. 88 Issue 8, p1234 

    Extrahepatic bile duct carcinoma (EBDC) is a malignancy well known for its poor prognosis. Some clinicopathological prognostic markers have been proposed, but genetic factors have not been well investigated. We have examined expression patterns of caveolin-I, which has been shown to function as...

  • A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer. Furuse, Junji; Okusaka, Takuji; Ohkawa, Shinichi; Nagase, Michitaka; Funakoshi, Akihiro; Boku, Narikazu; Yamao, Kenji; Yamaguchi, Taketo; Sato, Toshiya // Cancer Chemotherapy & Pharmacology;Dec2009, Vol. 65 Issue 1, p113 

    The purpose of this study was to clarify the safety and efficacy of combination chemotherapy of uracil-tegafur (UFT) and doxorubicin (UFD regimen), and to identify the prognostic factors in patients with unresectable advanced biliary tract cancer who received systemic chemotherapy. Patients with...

  • Capsaicin Treatment Attenuates Cholangiocarcinoma Carcinogenesis. Wutka, Annika; Palagani, Vindhya; Barat, Samarpita; Chen, Xi; El Khatib, Mona; Götze, Julian; Belahmer, Hanane; Zender, Steffen; Bozko, Przemyslaw; Malek, Nisar P.; Plentz, Ruben R. // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    Capsaicin, the most abundant pungent molecule produced by pepper plants, represents an important ingredient in spicy foods consumed throughout the world. Studies have shown that capsaicin can relieve inflammation and has anti-proliferative effects on various human malignancies....

  • Gene expression profiling of cholangiocarcinomaderived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker. Utispan, Kusumawadee; Thuwajit, Peti; Abiko, Yoshimitsu; Charngkaew, Komgrid; Paupairoj, Anucha; Siri Chau-in; Thuwajit, Chanitra // Molecular Cancer;2010, Vol. 9, p13 

    Background: Fibroblasts play important roles in several cancers. It was hypothesized that cholangiocarcinoma (CCA)-associated fibroblasts (Cfs) differ from non-tumorigenic liver fibroblasts (Lfs) in their gene expression profiles resulting in the capability to promote cancer. Periostin (PN) is a...

  • Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma. Westgaard, Arne; Tafjord, Svetlana; Farstad, Inger N.; Cvancarova, Milada; Eide, Tor J.; Mathisen, Oystein; Clausen, Ole Petter F.; Gladhaug, Ivar P. // BMC Cancer;2008, Vol. 8, Special section p1 

    Background: Resectable adenocarcinomas in the pancreatic head, by definition "periampullary", originate from ampullary, duodenal, biliary, or ductal pancreatic epithelium. Typically, periampullary adenocarcinomas have either intestinal or pancreatobiliary type of differentiation, and the type of...

  • Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapy. Tae Ryool Koo; Keun-Yong Eom; In Ah Kim; Jai Young Cho; Yoo-Seok Yoon; Dae Wook Hwang; Ho-Seong Han; Jae-Sung Kim // Radiation Oncology Journal;Jun2014, Vol. 32 Issue 2, p63 

    Purpose: To find the applicability of adjuvant radiotherapy for extrahepatic bile duct cancer (EBDC), we analyzed the pattern of failure and evaluate prognostic factors of locoregional failure after curative resection without adjuvant treatment. Materials and Methods: In 97 patients with...

  • Erratum to: Debating the Presentation, Morphology, Origin, and Prognosis of a Combined Hepatocellular-Cholangiocarcinoma. Lorenzon, Laura; Castaldo, Paolo; Bartolazzi, Andrea; Monte, Simone; Camboni, Alessandra; Pilozzi, Emanuela; Salvi, Pier; Ziparo, Vincenzo // Digestive Diseases & Sciences;Sep2013, Vol. 58 Issue 9, p2742 

    No abstract available.

  • Impact of residual in situ carcinoma on postoperative survival in 125 patients with extrahepatic bile duct carcinoma. Nakanishi, Yoshitsugu; Kondo, Satoshi; Zen, Yoh; Yonemori, Atsuya; Kubota, Kanako; Kawakami, Hiroshi; Tanaka, Eiichi; Hirano, Satoshi; Itoh, Tomoo; Nakanuma, Yasuni // Journal of Hepato -- Biliary -- Pancreatic Sciences;Mar2010, Vol. 17 Issue 2, p166 

    The aim of this study was to determine the impact of the presence of carcinoma in situ at the bile duct stump on postoperative survival in patients who underwent resection of extrahepatic bile duct carcinoma. The patients with resected extrahepatic bile duct carcinoma were divided into three...

  • PKM2 regulates neural invasion of and predicts poor prognosis for human hilar cholangiocarcinoma. Guanzhen Yu; Wenlong Yu; Guangzhi Jin; Dongyun Xu; Ying Chen; Tian Xia; Allan Yu; Wenzheng Fang; Xiaoli Zhang; Zhaosheng Li; Keping Xie // Molecular Cancer;11/14/2015, Vol. 14 Issue 1, p1 

    Background: The therapeutic and prognostic value of the glycolytic enzymes hexokinase, phosphofructokinase, and pyruvate kinase (PK) has been implicated in a variety of cancers, while their roles in treatment of and prognosis for hilar cholangiocarcinoma (HC) remain unclear. In this study, we...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics